Biobanking Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2027

Published on : Jan-2020 | List of Tables : 52 | List of Figures : 80 | No. of Pages : 170 | Report Code : FACT4438MR | Format :

Demand for Temperature Control Systems to Gain Strength in Biobanking Market

Growing trend of personalised medicines to reduce mortality rates caused by chronic diseases is fuelling demand for biobanks for the effective storage of numerous biospecimen, ranging from blood to tissues, cells, and nucleic acids. Sales of equipment for storing biospecimen would surge, and temperature control systems are projected to cross the US$ 1 Bn mark by 2027. A notable spurt in adoption of freezers for the preservation of biospecimen for their future use is likely to underpin growth of temperature control systems. However, a shift from manual to automated systems would boost opportunities for software and services during the forecast period (2020-2027).

A recent study on the biobanking market has been added to the broad repository of Fact.MR. According to the study, the biobanking market would advance at a healthy CAGR of 7% during the forecast period.

assessment of lucrative opportunities in biobanking market

For detailed insights on market taxonomy, request a sample copy of the report here.

High Operational Cost Concerns Portend Limited Adoption of Biobank Products

According to the study, technological advancements present a crucial challenge associated with cost. Integration of advanced technology means high cost of equipment and consumables, which, in turn, increases the operational costs of biobanks. For instance, in France and the Netherlands, the annual operational cost of a biobank ranges from US$ 220,000 to US$ 880,000. Besides this, cost associated with infrastructure, equipment, human resources, and supplies further make it an expensive working model. The high operational cost of biobanks reflects on the increasing price of storage for end users, which is leading to a low adoption rate of biobanks.

Therapeutics to Grow as Leading Application in Biobanking Market

There has been a shift in the healthcare sector from chemicals towards biospecimen for the development of therapeutics to treat chronic and rare disorders. This is gradually boosting demand for blood products, tissues, and human cells for the development of precision and regenerative medicines.

On account of this shift, therapeutics are expected to account for 38% share in the biobanking market by 2027. However, as healthcare professionals are looking at preventive rather than a curative approach, use of biospecimen for clinical diagnosis is likely to increase at a CAGR of around 7% during the forecast period. Several research institutes help clinics by studying cell structures to determine the root of chronic diseases, which is projected to strengthen sales from the clinical diagnosis of biospecimen.

key regions in the biobanking market

For detailed regional analysis, request a sample copy of the report here.

Asia Pacific Biobanking Market Surge Driven by China

There has been an increase in the number of biobanks in developing as well as developed countries of Asia Pacific, such as China, Japan, Singapore, South Korea, Thailand, and Australia. A significant thrust to the Asia Pacific biobanking market is offered by China, on account of ongoing advancements in the pharmaceutical industry, which is likely to increase demand for biospecimen for producing therapeutics. Government initiatives in the healthcare sector towards improving extant infrastructure through monetary aids, are, in turn, expanding the scope of the industry. In addition, there has been an increase in the number of biobanks in China, which holds a high potential to drive the sales of biobank products. On the back of China’s notable performance in the biobanking market, Asia Pacific is expected to witness the highest CAGR of around 8% during the forecast period.

Biobanking Market – Scope of the Study

The study on the biobanking market is an exclusive report published by Fact.MR, which brings to the fore crucial parameters that are driving the growth of the market. This exclusive study provides incisive insights regarding recent developments in the biobanking market, by analysing the historical data for the period of 2017-2019, with the duration of 2020-2027 being considered as the forecast period.

Evaluation of the biobanking market’s revenue has been carried out in terms of value (US$ Mn). This research provides information into the key trends that are potential enough to influence the growth of the biobanking market. Besides this, the study also includes several macroeconomic and microeconomic growth indicators complementing the growth of the biobanking market during the forecast period. This detailed study provides information into key dynamics, and their influence on the biobanking market during the forecast period.

The report also provides information about the key challenges and threats that could deter the growth potential of players in the biobanking market. The study unveils profitable opportunities for manufacturers, which they can adopt to strengthen their position in the global biobanking market. With a view of aiding stakeholders in the biobanking market, the study comprises a detailed section on the competition analysis.

This exclusive study offers a dashboard view of the biobanking market, with detailed information about market players, based on overall revenue, key developments, and their market presence. Additionally, key strategies of players in the biobanking market have also been included in this comprehensive study.

Biobanking Market – Assessment of Key Segments

Authors of this comprehensive study have classified the biobanking market into key segments for an in-depth study of the biobanking market. Categorisation of the biobanking market is based on storage, application, biospecimen, product, and region. This detailed study also offers information about the incremental opportunity present in the biobanking market during the forecast period. Key segments considered while studying the biobanking market include:

Storage

Application

Biospecimen

Product

Region

Manual

Therapeutics

Blood Products

Equipment

  • Temperature Control Systems
    • Freezers & Refrigerators
    • Cryogenic Storage Systems
    • Thawing Equipment
  • Incubators & Centrifuges
  • Alarms & Monitoring Systems
  • Accessories & Other Equipment

North America

Automated

Clinical Diagnostics

Human Tissues

Consumables

  • Cryovialsand Cryomolds
  • Tubes
  • Others

Europe

 

Drug Discovery & Development

Cell Lines

Software & Services

Asia Pacific

 

Others

Nucleic Acids

 

Latin America

 

 

Others

 

Middle East & Africa

Revenue of the biobanking market has been evaluated in terms of US$ Mn for the period of 2020 to 2027. In addition to this, compound annual growth rate has been calculated for all key segments for the forecast period of 2020-2027, considering 2019 as the base year.

Authors of this exclusive study on the biobanking market have analysed key players, based on their financials, products, and strategies, in order to provide key detailed information into the competitive landscape. Key players operating in the biobanking market include Thermo Fisher Scientific, Inc., Tecan Trading AG, PHC Holdings Corporation (Panasonic Healthcare), Merck KGaA, Hamilton Company, Brooks Automation, Inc., Chart Industries, Inc., Greiner AG, VWR International, LLC, and QIAGEN N.V.

This exclusive study is produced to offer a detailed perspective of the biobanking market to stakeholders. The report is also aimed at offering crucial information about the biobanking market to new players.

Request research methodology of this report.

Biobanking Market – Research Methodology

The primary objective of this exclusive study on the biobanking market is to offer precise estimates and forecasts of the market in terms of value (US$ Mn) for the period of 2020-2027. The secondary objective includes analysis of key market segments exhibiting significant growth rates, leading strategies adopted by players in the biobanking market, and the adoption rate of biobanking in key regions across the world.

1. Preface

    1.1. Report Scope and Market Segmentation 

    1.2. Research Highlights

2. Assumptions and Research Methodology 

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

    3.1. Global Biobanking Market: Market Snapshot

4. Market Overview

    4.1. Global Biobanking Market: Product Overview

    4.2. Global Biobanking Market: Key Industry Developments

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Biobanking Market Revenue Projections, 2020–2027

    4.5. Global Biobanking Market Outlook

5. Market Outlook

    5.1. Key Mergers & Acquisitions

    5.2. Technological Advancements

    5.3. Healthcare Industry Overview

    5.4. Regulatory Scenario by Region/globally

    5.5. List of Major Biobanks, by Region

    5.6. List of Vendors Supporting Automated Biobanking

6. Global Biobanking Market Analysis, by Product

    6.1. Key Findings

    6.2. Introduction

    6.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Product

    6.4. Global Biobanking Market Forecast, by Product 

        6.4.1. Equipment

            6.4.1.1. Temperature Control Systems

                6.4.1.1.1. Freezers & Refrigerators

                6.4.1.1.2. Cryogenic Storage Systems

                6.4.1.1.3. Thawing Equipment

                6.4.1.1.4. Incubators & Centrifuges

            6.4.1.2. Alarms & Monitoring Systems

            6.4.1.3. Accessories & Other equipment

        6.4.2. Consumables

            6.4.2.1. Cryovials & Cryomolds

            6.4.2.2. Tubes

            6.4.2.3. Others

        6.4.3. Software & Services

    6.5. Global Biobanking Market Analysis, by Product, 2020–2027

7. Global Biobanking Market Analysis, by Biospecimen

    7.1. Key Findings

    7.2. Introduction

    7.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen

    7.4. Global Biobanking Market Forecast, by Biospecimen

        7.4.1. Blood Products

        7.4.2. Human Tissues

        7.4.3. Cell Lines

        7.4.4. Nucleic Acids

        7.4.5. Others

    7.5. Global Biobanking Market Analysis, by Biospecimen, 2020–2027

8. Global Biobanking Market Analysis, by Application

    8.1. Key Findings

    8.2. Introduction

    8.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Application

    8.4. Global Biobanking Market Forecast, by Application

        8.4.1. Therapeutics

        8.4.2. Clinical Diagnostics

        8.4.3. Drug Discovery & Development

        8.4.4. Others

    8.5. Global Biobanking Market Analysis, by Application, 2020–2027

9. Global Biobanking Market Analysis, by Storage 

    9.1. Key Findings

    9.2. Introduction

    9.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Storage

    9.4. Global Biobanking Market Forecast, by Storage

        9.4.1. Manual

        9.4.2. Automated

    9.5. Global Biobanking Market Analysis, by Storage, 2020–2027

10. Global Biobanking Market Analysis, by Region

    10.1. Global Biobanking Market Scenario, by Country

    10.2. Global Biobanking Market Value Share and Attractiveness Analysis, by Region

    10.3. Global Biobanking Market Forecast, by Region

        10.3.1. North America

        10.3.2. Europe

        10.3.3. Asia Pacific

        10.3.4. Latin America

        10.3.5. Middle East & Africa

11. North America Biobanking Market Analysis

    11.1. Key Findings

    11.2. North America Biobanking Market Value Share and Attractiveness Analysis, by Country

    11.3. North America Biobanking Market Forecast, by Country

        11.3.1. U.S.

        11.3.2. Canada

    11.4. North America Biobanking Market Value Share and Attractiveness Analysis, by Product

    11.5. North America Biobanking Market Forecast, by Product

        11.5.1. Equipment

            11.5.1.1. Temperature Control Systems

                11.5.1.1.1. Freezers & Refrigerators

                11.5.1.1.2. Cryogenic Storage Systems

                11.5.1.1.3. Thawing Equipment

            11.5.1.2. Incubators & Centrifuges

            11.5.1.3. Alarms & Monitoring Systems

            11.5.1.4. Accessories & Other equipment

        11.5.2. Consumables

            11.5.2.1. Cryovials & Cryomolds

            11.5.2.2. Tubes

            11.5.2.3. Others

        11.5.3. Software & Services

    11.6. North America Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen

    11.7. North America Biobanking Market Forecast, by Biospecimen

        11.7.1. Blood Products

        11.7.2. Human Tissues

        11.7.3. Cell Lines

        11.7.4. Nucleic Acids

        11.7.5. Others

    11.8. North America Biobanking Market Value Share and Attractiveness Analysis, by Application

    11.9. North America Biobanking Market Forecast, by Application

        11.9.1. Therapeutics

        11.9.2. Clinical Diagnostics

        11.9.3. Drug Discovery & Development

        11.9.4. Others

    11.10. North America Biobanking Market Value Share and Attractiveness Analysis, by Storage

    11.11. North America Biobanking Market Forecast, by Storage

        11.11.1. Manual

        11.11.2. Automated

12. Europe Biobanking Market Analysis

    12.1. Key Findings

    12.2. Europe Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region

    12.3. Europe Biobanking Market Forecast, by Country/Sub-region

        12.3.1. Germany

        12.3.2. U.K.

        12.3.3. France

        12.3.4. Italy

        12.3.5. Spain

        12.3.6. Rest of Europe

    12.4. Europe Biobanking Market Value Share and Attractiveness Analysis, by Product

    12.5. Europe Biobanking Market Forecast, by Product

        12.5.1. Equipment

            12.5.1.1. Temperature Control Systems

                12.5.1.1.1. Freezers & Refrigerators

                12.5.1.1.2. Cryogenic Storage Systems

                12.5.1.1.3. Thawing Equipment

            12.5.1.2. Incubators & Centrifuges

            12.5.1.3. Alarms & Monitoring Systems

            12.5.1.4. Accessories & Other equipment

        12.5.2. Consumables

            12.5.2.1. Cryovials & Cryomolds

            12.5.2.2. Tubes

            12.5.2.3. Others

        12.5.3. Software & Services

    12.6. Europe Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen

    12.7. Europe Biobanking Market Forecast, by Biospecimen

        12.7.1. Blood Products

        12.7.2. Human Tissues

        12.7.3. Cell Lines

        12.7.4. Nucleic Acids

        12.7.5. Others

    12.8. Europe Biobanking Market Value Share and Attractiveness Analysis, by Application

    12.9. Europe Biobanking Market Forecast, by Application

        12.9.1. Therapeutics

        12.9.2. Clinical Diagnostics

        12.9.3. Drug Discovery & Development

        12.9.4. Others

    12.10. Europe Biobanking Market Value Share and Attractiveness Analysis, by Storage

    12.11. Europe Biobanking Market Forecast, by Storage

        12.11.1. Manual

        12.11.2. Automated

13. Asia Pacific Biobanking Market Analysis

    13.1. Key Findings

    13.2. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region

    13.3. Asia Pacific Biobanking Market Forecast, by Country/Sub-region

        13.3.1. China

        13.3.2. Japan

        13.3.3. India

        13.3.4. Australia & New Zealand

        13.3.5. Rest of Asia Pacific

    13.4. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Product

    13.5. Asia Pacific Biobanking Market Forecast, by Product

        13.5.1. Equipment

            13.5.1.1. Temperature Control Systems

                13.5.1.1.1. Freezers & Refrigerators

                13.5.1.1.2. Cryogenic Storage Systems

                13.5.1.1.3. Thawing Equipment

            13.5.1.2. Incubators & Centrifuges

            13.5.1.3. Alarms & Monitoring Systems

            13.5.1.4. Accessories & Other equipment

        13.5.2. Consumables

            13.5.2.1. Cryovials & Cryomolds

            13.5.2.2. Tubes

            13.5.2.3. Others

        13.5.3. Software & Services

    13.6. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen

    13.7. Asia Pacific Biobanking Market Forecast, by Biospecimen

        13.7.1. Blood Products

        13.7.2. Human Tissues

        13.7.3. Cell Lines

        13.7.4. Nucleic Acids

        13.7.5. Others

    13.8. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Application

    13.9. Asia Pacific Biobanking Market Forecast, by Application

        13.9.1. Therapeutics

        13.9.2. Clinical Diagnostics

        13.9.3. Drug Discovery & Development

        13.9.4. Others

    13.10. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Storage

    13.11. Asia Pacific Biobanking Market Forecast, by Storage

        13.11.1. Manual

        13.11.2. Automated

14. Latin America Biobanking Market Analysis

    14.1. Key Findings

    14.2. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region

    14.3. Latin America Biobanking Market Forecast, by Country/Sub-region

        14.3.1. Brazil

        14.3.2. Mexico

        14.3.3. Rest of Latin America

    14.4. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Product

    14.5. Latin America Biobanking Market Forecast, by Product

        14.5.1. Equipment

            14.5.1.1. Temperature Control Systems

                14.5.1.1.1. Freezers & Refrigerators

                14.5.1.1.2. Cryogenic Storage Systems

                14.5.1.1.3. Thawing Equipment

            14.5.1.2. Incubators & Centrifuges

            14.5.1.3. Alarms & Monitoring Systems

            14.5.1.4. Accessories & Other equipment

        14.5.2. Consumables

            14.5.2.1. Cryovials & Cryomolds

            14.5.2.2. Tubes

            14.5.2.3. Others

        14.5.3. Software & Services

    14.6. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen

    14.7. Latin America Biobanking Market Forecast, by Biospecimen

        14.7.1. Blood Products

        14.7.2. Human Tissues

        14.7.3. Cell Lines

        14.7.4. Nucleic Acids

        14.7.5. Others

    14.8. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Application

    14.9. Latin America Biobanking Market Forecast, by Application

        14.9.1. Therapeutics

        14.9.2. Clinical Diagnostics

        14.9.3. Drug Discovery & Development

        14.9.4. Others

    14.10. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Storage

    14.11. Latin America Biobanking Market Forecast, by Storage

        14.11.1. Manual

        14.11.2. Automated

15. Middle East & Africa Biobanking Market Analysis

    15.1. Key Findings

    15.2. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region

    15.3. Middle East & Africa Biobanking Market Forecast, by Country/Sub-region

        15.3.1. GCC Countries

        15.3.2. South Africa

        15.3.3. Rest of Middle East & Africa

    15.4. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Product

    15.5. Middle East & Africa Biobanking Market Forecast, by Product

        15.5.1. Equipment

            15.5.1.1. Temperature Control Systems

                15.5.1.1.1. Freezers & Refrigerators

                15.5.1.1.2. Cryogenic Storage Systems

                15.5.1.1.3. Thawing Equipment

            15.5.1.2. Incubators & Centrifuges

            15.5.1.3. Alarms & Monitoring Systems

            15.5.1.4. Accessories & Other equipment

        15.5.2. Consumables

            15.5.2.1. Cryovials & Cryomolds

            15.5.2.2. Tubes

            15.5.2.3. Others

        15.5.3. Software & Services

    15.6. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen

    15.7. Middle East & Africa Biobanking Market Forecast, by Biospecimen

        15.7.1. Blood Products

        15.7.2. Human Tissues

        15.7.3. Cell Lines

        15.7.4. Nucleic Acids

        15.7.5. Others

    15.8. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Application

    15.9. Middle East & Africa Biobanking Market Forecast, by Application

        15.9.1. Therapeutics

        15.9.2. Clinical Diagnostics

        15.9.3. Drug Discovery & Development

        15.9.4. Others

    15.10. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Storage

    15.11. Middle East & Africa Biobanking Market Forecast, by Storage

        15.11.1. Manual

        15.11.2. Automated

16. Competition Landscape

    16.1. Company Profiles

        16.1.1. Thermo Fisher Scientific, Inc. 

        16.1.2. PHC Holdings Corporation (Panasonic Healthcare) 

        16.1.3. Hamilton Company 

        16.1.4. Chart Industries, Inc. 

        16.1.5. VWR International, LLC. (Avantor, Inc.) 

        16.1.6. QIAGEN N.V. 

        16.1.7. Greiner AG 

        16.1.8. Brooks Automation, Inc.

        16.1.9. Merck KGaA 

        16.1.10. Tecan Trading AG

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Biobanking Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2027